Trial intelligence / Profile preview

Monitoring of flexor hallucis brevis muscle using acceleromyography after vecuronium

jRCT1090220107Completed

Sponsor
Yasuyuki Sugi
Start
Dec 2012
Modality
Small Molecules
Countries
1
01

Overview

Open-label, single-arm trial of vecuronium, sponsored by Yasuyuki Sugi. Primary endpoints: Difference in neuromuscular recovery time to TOFR 0.7 between upper-limb EMG and lower-limb AMG and Difference in neuromuscular recovery time to TOFR 0.9 between upper-limb EMG and lower-limb AMG. Started Dec 2012; status: completed.

02

Drugs

vecuronium

Beyond the preview

Go deeper on jRCT1090220107.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT1090220107.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call